Mercury Secures $200 Million in Latest Series D Funding Round

Mercury secured $200 million in its latest Series D, adding another data point to the Healthcare funding market.

Mercury Raises $200 million in Funding

Mercury: $200 Million Series D Raised At $5.2 Billion is a billion valuation that the San Francisco-based Digital Health company focused on use the funds to develop AI-native banking tools.

Investors Behind the Funding

The round was backed by TCV. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Mercury operates in Healthcare. Mercury: $200 Million Series D Raised At $5.2 Billion's Series D round shows investors are still backing digital health platforms with real scale narratives. At $200M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

use the funds to develop AI-native banking tools

Looking Ahead

Mercury: $200 Million Series D Raised At $5.2 Billion Valuation For AI-Native Banking Platform

Source reference: original announcement/article.